Blueline Healthcare Solutions Ltd 09379070 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is Healthcare Digita Accounts Production Advanced 6.30.9574.0 true 09379070 2022-04-01 2023-03-31 09379070 2023-03-31 09379070 bus:CompanySecretaryDirector1 1 2023-03-31 09379070 bus:OrdinaryShareClass1 2023-03-31 09379070 core:RetainedEarningsAccumulatedLosses 2023-03-31 09379070 core:ShareCapital 2023-03-31 09379070 core:CurrentFinancialInstruments 2023-03-31 09379070 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 09379070 core:Non-currentFinancialInstruments 2023-03-31 09379070 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 09379070 core:FurnitureFittingsToolsEquipment 2023-03-31 09379070 bus:SmallEntities 2022-04-01 2023-03-31 09379070 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 09379070 bus:FullAccounts 2022-04-01 2023-03-31 09379070 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 09379070 bus:RegisteredOffice 2022-04-01 2023-03-31 09379070 bus:CompanySecretaryDirector1 2022-04-01 2023-03-31 09379070 bus:CompanySecretaryDirector1 1 2022-04-01 2023-03-31 09379070 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 09379070 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 09379070 core:ComputerEquipment 2022-04-01 2023-03-31 09379070 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 09379070 countries:England 2022-04-01 2023-03-31 09379070 2022-03-31 09379070 bus:CompanySecretaryDirector1 1 2022-03-31 09379070 core:FurnitureFittingsToolsEquipment 2022-03-31 09379070 2021-04-01 2022-03-31 09379070 2022-03-31 09379070 bus:CompanySecretaryDirector1 1 2022-03-31 09379070 bus:OrdinaryShareClass1 2022-03-31 09379070 core:RetainedEarningsAccumulatedLosses 2022-03-31 09379070 core:ShareCapital 2022-03-31 09379070 core:CurrentFinancialInstruments 2022-03-31 09379070 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 09379070 core:Non-currentFinancialInstruments 2022-03-31 09379070 core:Non-currentFinancialInstruments core:AfterOneYear 2022-03-31 09379070 core:FurnitureFittingsToolsEquipment 2022-03-31 09379070 bus:CompanySecretaryDirector1 1 2021-04-01 2022-03-31 09379070 bus:CompanySecretaryDirector1 1 2021-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09379070

Blueline Healthcare Solutions Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

Blueline Healthcare Solutions Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Blueline Healthcare Solutions Ltd

Company Information

Director

Mrs Shamiso Winsor

Company secretary

Mrs Shamiso Winsor

Registered office

Office 128 Redwood House
Brotherswood Court
Almondsbury Business Park
Bristol
BS32 4QW

Accountants

K & N Accounting Ltd
60 Windsor Avenue
London
South West London
SW19 2RR

 

Blueline Healthcare Solutions Ltd

(Registration number: 09379070)
Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

4,733

6,311

Current assets

 

Debtors

5

57,561

16,745

Cash at bank and in hand

 

160

327

 

57,721

17,072

Creditors: Amounts falling due within one year

6

(33,426)

(4,321)

Net current assets

 

24,295

12,751

Total assets less current liabilities

 

29,028

19,062

Creditors: Amounts falling due after more than one year

6

(14,196)

(18,541)

Net assets

 

14,832

521

Capital and reserves

 

Called up share capital

7

2

2

Retained earnings

14,830

519

Shareholders' funds

 

14,832

521

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 19 June 2023
 

 

Blueline Healthcare Solutions Ltd

(Registration number: 09379070)
Balance Sheet as at 31 March 2023

.........................................
Mrs Shamiso Winsor
Company secretary and director

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Office 128 Redwood House
Brotherswood Court
Almondsbury Business Park
Bristol
BS32 4QW

These financial statements were authorised for issue by the director on 19 June 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer Equipment

33% Straighline

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2022

8,415

8,415

At 31 March 2023

8,415

8,415

Depreciation

At 1 April 2022

2,104

2,104

Charge for the year

1,578

1,578

At 31 March 2023

3,682

3,682

Carrying amount

At 31 March 2023

4,733

4,733

At 31 March 2022

6,311

6,311

5

Debtors

Current

2023
£

2022
£

Other debtors

57,561

16,745

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

33,426

4,321

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

8

14,196

18,541

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

7

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary of £1 each

2

2

2

2

         

8

Loans and borrowings

2023
£

2022
£

Non-current loans and borrowings

Bank borrowings

14,196

18,541

9

Dividends

   

2023

 

2022

   

£

 

£

Final dividend of £75,000.00 (2022 - £19,000.00) per ordinary share

 

75,000

 

19,000

         

10

Related party transactions

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Transactions with the director

2023

At 1 April 2022
£

Advances to director
£

At 31 March 2023
£

Mrs Shamiso Winsor

Advance

-

45,201

45,201

 

-

45,201

45,201

     

 

2022

At 1 April 2021
£

Advances to director
£

At 31 March 2022
£

Mrs Shamiso Winsor

Advance

-

16,745

16,745

 

-

16,745

16,745

     

 

 

Blueline Healthcare Solutions Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Director's remuneration

The director's remuneration for the year was as follows:

2023
£

2022
£

Remuneration

25,140

25,140